AI Stock Finder
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-06

AMPH vs CMPS: stock comparison and AI forecast

Amphastar Pharmaceuticals, Inc. (AMPH) and Compass Pathways Plc (CMPS) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Pharmaceutical Preparations

AMPH Amphastar Pharmaceuticals, Inc.

Price
$27.66 +15.1% · 6M
Market Cap
$1.18B
P/E Ratio
14.6x
Size
small-cap
AI Forecast
Full analysis →
Nasdaq · Pharmaceutical Preparations

CMPS Compass Pathways Plc

Price
$8.60 -11.9% · 6M
Market Cap
$1.08B
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

6M · 2026-05-07 → 2026-11-05

Six-month price performance

Closing prices rebased to 100 at the start of the window.

80100120140160
AMPH +15.1% CMPS -11.9%
AMPH · CMPS

Key facts

  • AMPH and CMPS have similar market capitalizations ($1.18B and $1.08B).
  • Over the last six months AMPH returned +15.1% and CMPS -11.9%.
  • CMPS carries 2.65 times debt per unit of equity, against 1.10 times for AMPH.
  • Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricAMPHCMPS
Market Cap$1.18B$1.08B
P/E Ratio14.63x–
P/B Ratio1.44x7.61x
EPS$1.89$-3.83
Book Value/Share$19.15$1.03
Revenue/Share$17.53–
FCF/Share$3.27–

Profitability & Margins

MetricAMPHCMPS
ROE12.2%-187.4%
ROA5.8%-51.3%
ROIC9.1%-102.3%
Gross Margin46.8%–
Operating Margin18.7%–
Net Margin13.3%–
EBT Margin17.4%–
Tax Rate23.6%1.3%

Financial Health

MetricAMPHCMPS
Current Ratio3.32x1.50x
Quick Ratio2.36x–
D/E Ratio1.10x2.65x
Financial Leverage2.10x3.65x
Interest Coverage6.7x-35.3x
Working Capital$421M$162M

Cash Flow

MetricAMPHCMPS
Operating Cash Flow$175M-$177M
Free Cash Flow$139M–
Capital Spending-$36M–
OCF Growth YoY15.1%–
FCF Growth YoY22.8%–
FCF/Sales18.6%–
CapEx/Sales4.9%–

Operational Efficiency

MetricAMPHCMPS
Asset Turnover0.44x–
Receivables Turnover4.1x–
Inventory Turnover2.3x–
Fixed Assets Turnover2.4x–
Days Sales Outstanding89 days–
Days Inventory160 days–
Payables Period32 days–
Cash Conversion Cycle217 days–

Income Statement

MetricAMPHCMPS
Total Revenue$746M–
Operating Income$140M-$198M
Net Income$99M-$266M
R&D Expense$92M$109M
SG&A Expense$169M–
Cost of Goods Sold$397M–

Dividend & Shareholder Information

MetricAMPHCMPS
Shares Outstanding43M138M
Net Income Growth-11.3%–
EPS Growth-26.2%-100.7%
FAQ

AMPH vs CMPS: stock comparison and AI forecast

Which is bigger, AMPH or CMPS?

AMPH and CMPS have similar market capitalizations ($1.18B and $1.08B).

Which stock performed better over the last six months, AMPH or CMPS?

Over the last six months AMPH returned +15.1% and CMPS -11.9%.

Which one does Intratio's AI model rank higher, AMPH or CMPS?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.